Size: px
Start display at page:

Download ""

Transcription

1

2

3

4

5

6 3

7 O157:H7 O139 VRSA H5N1) Nipah SARS prairie dog Chikungunya 4

8 H H A B B H C D 5

9 6

10 I.U.WHOCDC 7

11 MMWR VERO 8

12 100%92.3% 86.3% 40 % 50%12.5% 2.5% 30.8%

13 1(1) 26(19) 2(2) 1(1) 30(23) 0 24(18) 4(3) 2(1) 30(22) 0 75(21) 5(4) 0 80(25) 0 16(14) 2(2) 2(2) 20(18) 1(1) 13(11) 3(3) 1(1) 18(16) ( ) Nalidixic Acid () H H H 10

14 11

15 , 12

16 A 13

17

18 15

19 16

20 17

21 ( 250mg/ 100mg/ 18

22 19

23 20

24 21

25 GabonCongo Leroy, EM et al, Nature 2005;438:575-6 EV) Vesicular Stomatitis Virus (VSV)EV EV Plos Pathog. 2007;3(1):e2. 22

26 Mr. U.G 1 23

27 Child: Secondary lesions 5/27/03, adjacent to primary inoculation site on left hand. Marshfield Clinic Monkeypox lesions at a finger bitten by a prairie dog Marshfield Clinic / 0/0 0/0 0/0 8/58/5 0/0 0/0 4/4 2/2 6/6 1/1 0/0 8/5 12/8 21/14 0/0 0/0 0/0 1/0 1/0 0/0 0/0 0/0 15/6 15/6 0/0 0/0 19/12 50/40 69/52 0/0 0/0 0/0 3/2 3/2 0/0 17/12 5/2 3/3 8/5 0/0 0/0 0/0 12/4 12/4 3/3 29/20 61/19 0/0 93/42 4/4 46/32 97/42 106/ /148 24

28 in vitro 25

29 26

30 27

31 28

32 29

33

34 Prevention important B A () 1

35 A8,000 * 2

36 A ProMED 4/

37

38 B

39 0 6

40 1970 7

41 * 8

42 9

43

表1_表4

表1_表4 HN- 95 HN- 93 HN- 90 HN- 87 HN- 85 HN- 82 HN- 80 HN- 77 HN- 75 HN- 72 HN- 70 HN- 67 HN- 65 HN- 60 HN- 55 HN- 50 HN- 45 HN- 40 HN- 35 HN- 30 HN- 25 HN- 20 HN- 15 HN- 10 H02-80H H02-80L H02-70T H02-60H H05-60F

More information

(1) 2000 ( ) ( ) 1000 2000 1000 0 http://www.spacepark.city.koriyama.fukushima.jp/ http://www.miraikan.jst.go.jp/ http://www.nasda.go.jp/ 3000 1 1 http://www.city.nara.nara.jp/citizen/jyugsidu/jgy/jsj/

More information

Microsoft Word - 表紙資料2-4

Microsoft Word - 表紙資料2-4 (1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)

More information

1 z q w e r t y x c q w 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 R R 32 33 34 35 36 MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR

More information

!!! 10 1 110 88 7 9 91 79 81 82 87 6 5 90 83 75 77 12 80 8 11 89 84 76 78 85 86 4 2 32 64 10 44 13 17 94 34 33 107 96 14 105 16 97 99 100 106 103 98 63 at 29, 66 at 58 12 16 17 25 56

More information

untitled

untitled 18 12 10 40 H5N1 2005 11 WHO 2005 12 2006 6 (H5N1) 10 25 1,700 ( 1,300 2,500 ) 200 53 64 17 30% 3,785,000 291,200 3 14,100 4 30% 57,600 4,430 3 1,150 320 210 4 2% 0.56% () ) 1 10 2 3A (2B) 3B 4A5A 6A 4B

More information

平成18年度 第1回 海域ワーキンググループ 議事録 [PDF]

平成18年度 第1回 海域ワーキンググループ 議事録 [PDF] - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - adjacent area - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 -

More information

2009 Aida et al. Caries Res 2006;40 2000 100 % 78.7 88.0 96.6 98.8 98.8 98.8 100.0 100.0 100 75 69.4 50 75.3 74.8 73.3 73.1 73.0 72.4 71.8 71.7 51.7 40.2 69.4 68.8 73.6 25 22.3 32.8 21.9 22.9 22.1

More information

001-007 扉・口絵・目次

001-007 扉・口絵・目次 1 6 6 7 1 a a a a 2 a a a 3 4 5 a 6 7 8 9 10 a 11 a a a 12 13 14 15 a 16 17 18 19 20 21 22 23 24 b b 25 b 26 27 aa 28 r r 29 a s d f 30 b b 31 32 33 1 34 35 36 37 38 6 39 6 40 41 42 43 44 45 7 47 48

More information

nsg02-13/ky045059301600033210

nsg02-13/ky045059301600033210 φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

More information

Small Animal Clinic C O N T E N T S NO.161 2 4 10 20 30 28 32 34 3 Small Animal Clinic No.161 4 5 6 Small Animal Clinic No.161 7 8 Small Animal Clinic No.161 9 Small Animal Clinic No.161 10 11 Small Animal

More information

Small Animal Clinic NO.146 C O N T E N T S 2 4 11 16 19 24 28 30 34 3 3 Small Animal Clinic No.146 4 5 Small Animal Clinic No.146 6 7 Small Animal Clinic No.146 8 9 11 Small Animal Clinic No.146 12 13

More information

Small Animal Clinic C O N T E N T S NO.154 2 4 10 18 28 31 32 34 3 3 Small Animal Clinic No.154 4 5 Small Animal Clinic No.154 6 7 Small Animal Clinic No.154 8 9 Small Animal Clinic No.154 10 11 Small

More information

産衛誌57-4たより.indb

産衛誌57-4たより.indb A89 26 7 1 9 4 33 1 87 A90 24 A91 23 ACOH2014 A92 4 1 2 3 4 5 6 7 A93 A94 A95 A96 A97 A98 A99 A100 A101 27 8 1 9 A102 4 33 A103 A104 26 3 140 27 1 A105 27 A106 A107 A108 A109 A110 A111 A112 A113 et al

More information

/‚“1/ŒxŒ{‚×›î’æ’¶

/‚“1/ŒxŒ{‚×›î’æ’¶ 60 1 pp.3-8 2010 1. H1N1 1) 2) 3) 4) ERATO 2009 H1N1 21 H1N1 HA PB2 2009 3 Pandemic H1N1 2009 WHO 6 11 21 2009 11 2010 4 21 H1N1 H1N1 2009 4 15 CDC 108-8639 4-6-1 TEL: 03-5449-5281 FAX: 03-5449-5408 E-mail:

More information

表1.eps

表1.eps Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol

More information

untitled

untitled 6 ( ). 1.. 1. 2. 3. 4. 5. ( ) 6. 7. 8. . 1. 1) 1 (12 3 ) 2 2) 3) ( ) ( ) 4) 2 () 2 2 3 5) ( ) R-Book ATLAS () 8 12 7 18 14 16 10 21 14 23 16 18 16 18 12 25 4 14 21 1 4 2 3 4 4 1 2 7 5 1 2 5 7 9 1 1 5 5

More information

200mg 2005 3 876179 2002 3 3 200mg VFEND for Intravenous Use (1) (2) [4.1 ] (3) [4.2 ] (1) [1] (2) (3) [1] 3

More information

21世紀という時代

21世紀という時代 1 2 3 http://www.biosecuritysummit.com 4 5 6 7 8 - 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 Source: Newspaper in HongKong

More information

131 1 74 1 4 19955% 5 19951% 74 51,4.34.9 7 1 8 4 88.5 48.3 49.4 49.8 49. 51.4 95 3 4 5 18. 18 17. 1. 1.8 1. 1 5 5. 14 4 1 4.1 4. 4. 4.1 1 3 8 4 1 3 4

131 1 74 1 4 19955% 5 19951% 74 51,4.34.9 7 1 8 4 88.5 48.3 49.4 49.8 49. 51.4 95 3 4 5 18. 18 17. 1. 1.8 1. 1 5 5. 14 4 1 4.1 4. 4. 4.1 1 3 8 4 1 3 4 515, 1 3 4 54,t 1 3 4 5 5 559 1 547 5 58 54 5 8 4 7.1 3 5. 5.9 5. 4.5 4 1 3 4 5 19 131 1 74 1 4 19955% 5 19951% 74 51,4.34.9 7 1 8 4 88.5 48.3 49.4 49.8 49. 51.4 95 3 4 5 18. 18 17. 1. 1.8 1. 1 5 5. 14

More information

医薬品リスク管理計画書

医薬品リスク管理計画書 2.5 mg 3.75 mg 5 mg 20mg RMP 2.5 mg 3.75 mg 5 mg 20mg 87339 28 6 1.1 4 8 10 5 8 10 5 TTP 9 梗 6 TIA 11 6 1.2 11 CABG 12 12 13 13 15 2.5mg 15 2. 16 3. 16 4. 19 19 19 18 RMP 28 6 3 5 1 27 8 25 26 3 24 87339

More information

2011 2011 2011 100/m 0.003/ 0.0005 / 0.01/ 0.01 / 0.01/ 0.05 / 0 0.0003 0.00005 0.001 0.001 0.001 0.005 0 0.0003 0.00005 0.001 0.001 0.001 0.005 0 0.0003 0.00005 0.001 0.001 0.001 0.005 0 0.0003 0.00005

More information

IF_SUPRECUR_N29

IF_SUPRECUR_N29 ! @ # $ % ^ & * ( ) _ + )# ! a s d a s d f g h a s d @ a s d a s # a s d f g h j $ a s d f g h a s d % a s a a s a s a s d f g ^ a s a s a s & a s d f a s d f g h a s d f g a s d f g a s d a s d * s

More information

HIV1 IAS-USA 1 HIV 1 Amino Acid, Wild-Type Primary Mutation Amino Acid Substitution M I 54 Secondary Mutation Codon Mutation Selected In Vitro MUTATIONS IN THE PROTEASE GENE SELECTED BY PROTEASE INHIBITORS

More information

KRAS KRAS

KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS : KRAS in vitro KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS

More information

untitled

untitled 25 486 1 17 3 1641 1 OA OA 1F 726 2F 662 F 1F 137 2F 1,321 3F 1,312 1,513 F 1,292 2F 1,155 1F 747 2F 747 40 2,770 3F 1,415 F F 1,494 18 508 EV EV ) ) 40kw 2~3 30m 777 16 1 16 16 7 16 800,000 790,000

More information

437“ƒ

437“ƒ et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer

More information

中国の憲法改正

中国の憲法改正 2004 10 13 11 13 14 33 67 80 89 16 10 59 81 98 136 1982 12 1988 1993 1999 20 04 2004 1987 13 1988 1992 14 1993 1997 15 1999 2002 16 2004 60 2002 11 12 20 2003 10 28 2003 6 2003.10.28, 2003, p.16 2002 2002,

More information

untitled

untitled 1 4 4 6 8 10 30 13 14 16 16 17 18 19 19 96 21 23 24 3 27 27 4 27 128 24 4 1 50 by ( 30 30 200 30 30 24 4 TOP 10 2012 8 22 3 1 7 1,000 100 30 26 3 140 21 60 98 88,000 96 3 5 29 300 21 21 11 21

More information

: : 2001227 : 2

: : 2001227 : 2 : : 2001227 : 2 mg/100gmg/100g mg/100g 3 10/102006 12/05 2/19, 2007 Zn 63 98 4 10% 5 Ramesh et al. 2004 6 Connoly et al. 2002 A IRT 7 8 2.11mg/100g143%56% 9 10 Alaria praelonga 11 2 12 13 14 15 16 1 1

More information

slide1.dvi

slide1.dvi 1. 2/ 121 a x = a t 3/ 121 a x = a t 4/ 121 a > 0 t a t = a t t {}}{ a a a t 5/ 121 a t+s = = t+s {}}{ a a a t s {}}{{}}{ a a a a = a t a s (a t ) s = s {}}{ a t a t = a ts 6/ 121 a > 0 t a 0 t t = 0 +

More information

冊子_H26-03A

冊子_H26-03A 1 : [ ] by kouyou_room 2014-02-28 22:18 Comments(6) Commented by at 2014-03-01 10:27 x 2 Commented by at 2014-03-01 10:29 x Commented by at 2014-03-01 10:54 x Commented by at 2014-03-01 14:50 x Commented

More information

13●53頁●6-7▲院内感染対策▲.ppt

13●53頁●6-7▲院内感染対策▲.ppt No.610 1 No.121 2 No.128 Nosocomial infection, Hospital-acquired infection CDC nosocomial infection, hospital-acquired infection nosocomial nosokomeion hospital nosocomial infection nosocomial pneumonia

More information

untitled

untitled 28 2016 26 28 4 1 28 2 4 (AMR) AMR RS A (SFTS) 鞭 29 12 20 1 4 6 7 7 7 8 13 21 22 23 24 25 26 28 30 32 33 34 35 36 40 66 70 78 84 87 87 89 92 92 93 105 105 105 106 107 108 109 110 111 111 112 112 112

More information

14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0

More information

20●12頁●6-14▲放射線科▲.ppt

20●12頁●6-14▲放射線科▲.ppt No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%

More information

2.2 (1967) (1997,2003) 2.2 ( ) 11

2.2 (1967) (1997,2003) 2.2 ( ) 11 ( ) 2.1 10 2.2 (1967) (1997,2003) 2.2 ( ) 11 12 ( ) 90150 (684) (887) (1099) (1361) (1605) (1707) (1854) 21(1946) 8 2.3 (1854) 13 (1997) (1854.12.23) (M8.4) (24 ) (M8.4) 70,000 3000 ( ) 7 2 3 3 (,1997)

More information

[2] 2, 3 ( wrapfigure ) 2: 3: [3] [1] (1841). [2] (1886). [3] -.

[2] 2, 3 ( wrapfigure ) 2: 3: [3] [1] (1841). [2] (1886). [3] -. 80kg ( 1) C 60 1: ( Aρχiµήδηç) r(z) = 0.5 1 (e z 2) 2 ln 3 V = π r 2 (z)dz (1) 0 1: (kg/) 20mg 8 2.5mg 5t 4 1.3t 60kg 2 30kg 10kg 1 10kg 7kg 0 19 [1] [2] 2, 3 ( wrapfigure ) 2: 3: [3] [1] (1841). [2] (1886).

More information

[ml] 180 160 140 120 100 80 60 40 20 0 Cumulative biogas production [ml/mg-input VS] 0 10 20 30 40 50 60 [] 1 0.8 0.6 0.4 0.2 0 dog food PLA foam 0 10 20 30 40 50 days RUN1-1 RUN1-2 RUN2-1 RUN2-2 RUN3-1

More information

Untitled art 3

Untitled art 3 2004 5 What s Inside 1 2 3 4 6 9 11 12 Visit our site at www.jccc-chi.org MAY 2004 NEWS CHICAGO 2 MAY 2004 NEWS CHICAGO 3 4 NEWS CHICAGO MAY 2004 MAY 2004 NEWS CHICAGO 5 6 NEWS CHICAGO MAY 2004 MAY 2004

More information

日本損害保険協会

日本損害保険協会 1995 1981 30cm 15cm 10cm 10cm 1998 38 24 78 0.5 1,0002,000 1984 2 1995 38 1995 1981 4 0.3 0.30.20.02 1 ex. 1960 km Body Wave Surface Wave Body Wave Primary wave Secondary

More information

1 1881 14 1870 80 1870 1877 10 23 2 3 2 2 24 25 6 1884 17 1 1886 19 1 2 1879 12 1874 7 1879 1884 26 1884.11.2 1884.1.12. 1869 1878 1882 15 5 1884.5.1. 5.10. 27 Oh Lord Amen 1884.5.25. 2 28 2 2 2 2 29 3

More information

:,, : - 7 -

:,, : - 7 - 31 ~ ~ - 6 - :,, : - 7 - (),,,,,,; ~ ~ *1 *2 6,,,~,,~ - 8-32 ,, ( );( ),,,,,, ~ ~ ~,,,, (),,,,, - 9 - 33 ~*~ ~~ ~, ~ ~ ~ ~ ~, ~~,,,, - 10 - BCG () g ) BCG BCG,, 34 ,,,, (),,,,,,,,,,,,,, () ( 3 90 [7 6

More information

untitled

untitled HCV 150 HCV 13 3 13 4 13 8 14 2 14 2 14 8 15 3 15 8 17 3 7 8 18 3 ----- i Q1 1 Q2 1 Q3 1 Q4 2 Q5 3 Q6 3 Q7 3 Q8 4 Q9 4 Q10 : 5 6 Q1 6 Q2 7 Q3 7 8 Q4 8 Q5HCV 8 Q6HCV 9 Q7HCV 9 Q8NAT 10 Q9 10 Q10 11 Q11

More information

7th埼玉オープン.pm6

7th埼玉オープン.pm6 6 7 6 7 6-0 6 7 0 6-6 -0 7-0 -7 8 8 - - 9 0 0 - -8 9 0-6 -8 0 8- -7-6 6-0 -7 7 0 8-8 (by Mitsuhashi) 6 0- -8 6 7 8 6 7 9 0-8 8 9 0 7 6 8 9-8 6-8 0 7-7 - 8 9 0 - -0 7 6 6-7 - - - 9- -6 9 0 8-8 -0 - -7-7

More information

Establishment and progress of Sendai virus engineering 2) Schnell, M. J., Mebatsion, T., Conzelmann, K.-K.: EMBO J., 13,4195-4203(1994) 3) Kato, A. et al.: Genes Cells, 1, 569-579 (1996) 4) Nagai,

More information

日本目録規則1987年版改訂2版第2章図書改定案

日本目録規則1987年版改訂2版第2章図書改定案 2.0.1 2.0.2 2.0.3 2.0.4 2.0.5 2.0.6 2.1.1 2.1.2 2.1.3 2.1.4 2.1.5 2.2.1 2.2.2 2.2.3 2.2.4 2.4.1 2.4.2 2.4.3 2.4.4 2.5.1 2.5.2 2.5.3 2.5.4 2.6.1 2.6.2 2.6.3 2.6.4 2.6.5 ISSN 2.6.6 2.6.7 2.7.1 2.7.2 2.7.3

More information

BAANs理論に基づく保健指導プログラム暫定版

BAANs理論に基づく保健指導プログラム暫定版 WHO 4 5 10% L- -3 RNA L - 1960-3 RNA mrna Bio Activating Advanced Nutrients BAANs BAANs BAANs BAANs L- (NO) -3 EPA, DHA) RNA RNA DNA TNF- PAI-1 ( ) BAANs 40 50% 20% 1Kg 7,000Kcal 50Kcal 11 50Kcal

More information

14UNAIDS HIV 39% i 9 ii9iii UNAIDS x.9x.9x1= ?? UNAIDS % 77%8% 44.7x.77x.8x1=

14UNAIDS HIV 39% i 9 ii9iii UNAIDS x.9x.9x1= ?? UNAIDS % 77%8% 44.7x.77x.8x1= DeCEMBER, 17 No.34 HIV 169-73 1-1-1-13TEL 3-5937-4413:3 19:3 FAX 3-5937-443E-mail info@janpplus.jp http://janpplus.jp/!9-9-9!... 1-3 POSITIVE HIV/AIDS UNAIDS!... 4-5 JaNP+HIV Cafe Bar an opportunity...

More information

200812 06 Development 2

200812 06 Development 2 200812 06 Development 2 200812 06 Research and Clinical Center for Child Development 4 (CP) MR MR, MR, MR( PDD, PDD, ADHD, 200812 06 Research and Clinical Center for Child Development 5 LD LD ADHD ADHD

More information

VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3

VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3 VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3 2 OptiView ALK D5F3 11 10 79.3%31% 18% 80 85NSCLC 40% 1,2 1 1018 ALK ALK 2 ALK 3 5% ALK EML4 EML4-ALK Coild-Coil ALK ALK 3,4,5 2 6 EGFR 50%

More information

/fiÁ1-1/‹Éfi¡ıæ„[’æ’¶

/fiÁ1-1/‹Éfi¡ıæ„[’æ’¶ 59 1 pp.53-58 2009 1. H5N1 3 H5N1 2007 1 2 2008 4 5 2003 H5N1 2005 50 1 429 262 2009 5 22 2 680-8553 4 101 TEL/FAX : 0857-31-5437 E-mail: toshiito@muses.tottori-u.ac.jp 3 H5N1 1 A A A 54 59 1 4 A A 5 1997

More information

近畿中国四国農業研究センター研究報告 第7号

近畿中国四国農業研究センター研究報告 第7号 230 C B A D E 50m 558 0 1km (mg L 1 ) T N NO 2 3 N NH 4 N 2.0 0 (a) 2001 1.5 6 20 21 5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 14:00 17:00 (b) 2001 7 3 4 20:00 23:00 2:00 (h) 5:00 8:00 11:00 10 0 5 10 15

More information

CHEMOTHERAPY JUNE 1986

CHEMOTHERAPY JUNE 1986 VOL. 34 S-3 CHEMOTHERAPY Fig. 1 Structural formula of L-105 CHEMOTHERAPY JUNE 1986 VOL. 34 S-3 CHEMOTHERAPY Table 1 Antibacterial spectra of L-105 against gram negative anaerobic rods Inoculum 106 cells/ml

More information

w NEWS NEWS Y

w NEWS NEWS Y No.472 FEB. 200315 w NEWS NEWS Y e r Y E t 1 1 y u i B 1 1 Y c fa g f o p mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr A 1 !0 1 1

More information

untitled

untitled ---------- - 1 - ----- 1 Q1 5 Q2 5 Q3 5 Q4 6 Q5 6 Q6 7 Q7 7 Q8 7 Q9 8 Q10 : 8 10 Q1 10 Q2 11 Q3 11 12 Q4 12 Q5 HBs HBc _12 Q6 HBe 12 Q7 13 Q8 NAT 15 Q9 15 Q10 15 Q11 HBs 16 Q12 HBV DNA 16 Q13 17-2 - Q14

More information

第3章 焼却灰溶融システムの現状、焼却灰溶融スラグのリサイクルの動向・問題点

第3章  焼却灰溶融システムの現状、焼却灰溶融スラグのリサイクルの動向・問題点 18 5 23 450 100~150 1300 1998 10 25 1 1 27 1819 60 3 300t 28.8t 2 62 118t16 12.3 16h 24 3 4 120t 9.6t24h 3 4 100t24h 15t24h 3 4 600t24h 500t24h 5 2 300t24h 75t24h 6 8 80 24h 9.6 24h 4 300t24h 52 24 11

More information

2 W.T T.S. 70 2 1 238 WBC7400/µl, RBC 386 10 4 /µl, Hb 11.6 g/dl, Ht 36.2%, PLT 25 10 4 /µl AST 19 IU/l, ALT 11 IU/l, LDH 182 IU/l, BUN 15 mg/dl, Cr 0.54 mg/dl, CRP6.83 mg/dl, RF 353.9IU/ml, CCP 28.0IU/ml

More information

MI( MI() 100% 100% 75% 75% 33% 75% 60% 40% 25% 60% 1 2 3 4 5 6 7 8 9 () 12 () () () !! 1. 2. 3. 1. 2. () () () 3-5% ex. ex. 11 ex. () ex. ex. : ex. : (insula) () () ( 2009 ) () ( ) YES! ()

More information

untitled

untitled E-mail: khatano@fms.saitama-u.ac.jp Tel & Fax: 048-858-3535 Toxin Virus Bacterium Glycolipid Glycoprotein Vero toxin (Stx1 and Stx2) Side view Bottom view H H H H N H Grobotriaosyl Ceramide (Gb 3 : Galα1-4Galβ1-4Glcβ-Cer)

More information

untitled

untitled 16 1109 2005 3 1109 1 16 1109 2 1 5 1 2 3 2 15 1 2 3 3 24 1 2 2 16 1109 1 colere nature 2 1 1982 P, 2 1967 P,135 136 3 16 1109 1 70 2 1 1997 P,68 2 2003 P,203 206 4 16 1109 5 16 1109 1 2 3 4 1 1982 P,17

More information

›Áfi¡ŒÎ“F’æ’¶

›Áfi¡ŒÎ“F’æ’¶ Shigetaka KATOW 2002 12 13 2 CDC Centers for Disease Control and Prevention CDC TV Dr. Julie L. Gerberding CDC 1 2001 9 11 2001 7 3 2 TV 60 2009 2 1 3 50 30 1976 1 5 BC1157 1 DNA DNA RNA 0100-0006 - -

More information

A5_Catalog-US-JN_ indd

A5_Catalog-US-JN_ indd 66 22 g 13 g 8 g 5 g 7500 IU 150% 300 mg 600 IU 100 IU 80 mcg 3 mg 3.5 mg 40 mg 4 mg 500 mcg 12 mcg 300 mcg 20 mg 1000 mg 150 mcg 400 mg 15 mg 105 mcg 2 mg 2 mg 180 mcg 125 mcg 15 mg 3.6 g ** 3.8 g **

More information